%0 Journal Article %T Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension. %A Ghio S %A Badagliacca R %A D'Alto M %A Scelsi L %A Argiento P %A Brunetti ND %A Casu G %A Cedrone N %A Confalonieri M %A Corda M %A Correale M %A D'Agostino C %A De Tommasi E %A Filomena D %A Galgano G %A Greco A %A Grimaldi M %A Lombardi C %A Madonna R %A Manzi G %A Mercurio V %A Mihai A %A Mulè M %A Paciocco G %A Papa S %A Recchioni T %A Romaniello A %A Romeo E %A Stolfo D %A Vitulo P %A Benza RL %A Vizza CD %A %J J Heart Lung Transplant %V 0 %N 0 %D 2024 Jun 26 %M 38942159 %F 13.569 %R 10.1016/j.healun.2024.06.003 %X BACKGROUND: Right ventricular (RV) imaging has not a definite role in risk stratification of pulmonary arterial hypertension (PAH) patients. We tested the hypothesis that echocardiography-derived phenotypes, depicting different degrees of RV remodeling and dysfunction, may provide additional prognostic information to current risk stratification tools.
METHODS: Consecutive incident PAH patients aged ≥18 years, diagnosed between January 2005 and December 2021, underwent clinical assessment, right heart catheterization, standard echocardiography. Simple echocardiographic variables were combined in order to define a priori four phenotypes representing different degrees of RV dilatation and RV-pulmonary arterial (PA) coupling: Phenotype 1 with mildy dilated right ventricle and preserved RV-PA coupling (n = 152 patients); phenotype 2 with mildly dilated right ventricle and poor RV-PA coupling (n = 143 patients); phenotype 3 with severely dilated right ventricle and preserved RV-PA coupling (n = 201 patients); phenotype 4 with severely dilated right ventricle and poor RV-PA coupling, with or without severe tricuspid regurgitation (n = 519 patients). Risk stratification was based on the European Society of Cardiology/European Respiratory Society (ESC/ERS) 3-strata model and Registry to Evaluate Early and Long-Term PAH disease Management (REVEAL) 2.0 score.
RESULTS: These phenotypes were present in all risk groups. Notably, regardless of the ESC/ERS risk stratum assigned to the patient, phenotype 4 was associated with a 2-fold increase of the odds of death (HR 2.1, 95% CI 1.6-2.8, p < 0.001), while phenotype 1 was associated with a 71% reduction in the odds of dying (HR 0.29, 95% CI 0.18-0.47, p < 0.001).
CONCLUSIONS: Echocardiography-derived phenotypes describing RV remodeling and dysfunction may provide prognostic information which is independent of and additional to the clinically defined risk in incident PAH patients.